- call +1-201-465-4211
- email sales@mrinsights.biz
Bone morphogenetic proteins (BMPs) are growth factors that induce the formation of bone after a fracture. In nature, these proteins have a critical role during embryonic development in the formation of the skeleton.
Scope of the Report:
This report focuses on the Bone Morphogenetic Protein in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Bone Morphogenetic Protein is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Fidia
Medtronic
TRB Chemedica
Meda Pharma
Sanofi Genzyme
Depuy Synthes
Bioventus
Laboratoire Genevrier
Recordati
Stryker
RTI Biologics
Croma-Pharma
Zimmer Biomet
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
rhBMP-2
rhBMP-7
Market Segment by Applications, can be divided into
Spinal Fusion
Trauma
Reconstruction
Oral Maxillofacial
There are 15 Chapters to deeply display the global Bone Morphogenetic Protein market.
Chapter 1, to describe Bone Morphogenetic Protein Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bone Morphogenetic Protein, with sales, revenue, and price of Bone Morphogenetic Protein, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bone Morphogenetic Protein, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bone Morphogenetic Protein market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bone Morphogenetic Protein sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bone Morphogenetic Protein Introduction
1.2 Market Analysis by Type
1.2.1 rhBMP-2
1.2.2 rhBMP-7
1.3 Market Analysis by Applications
1.3.1 Spinal Fusion
1.3.2 Trauma
1.3.3 Reconstruction
1.3.4 Oral Maxillofacial
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Fidia
2.1.1 Business Overview
2.1.2 Bone Morphogenetic Protein Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Fidia Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic
2.2.1 Business Overview
2.2.2 Bone Morphogenetic Protein Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 TRB Chemedica
2.3.1 Business Overview
2.3.2 Bone Morphogenetic Protein Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 TRB Chemedica Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Meda Pharma
2.4.1 Business Overview
2.4.2 Bone Morphogenetic Protein Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Meda Pharma Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi Genzyme
2.5.1 Business Overview
2.5.2 Bone Morphogenetic Protein Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Genzyme Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Depuy Synthes
2.6.1 Business Overview
2.6.2 Bone Morphogenetic Protein Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Depuy Synthes Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bioventus
2.7.1 Business Overview
2.7.2 Bone Morphogenetic Protein Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bioventus Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Laboratoire Genevrier
2.8.1 Business Overview
2.8.2 Bone Morphogenetic Protein Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Laboratoire Genevrier Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Recordati
2.9.1 Business Overview
2.9.2 Bone Morphogenetic Protein Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Recordati Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Stryker
2.10.1 Business Overview
2.10.2 Bone Morphogenetic Protein Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Stryker Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 RTI Biologics
2.11.1 Business Overview
2.11.2 Bone Morphogenetic Protein Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 RTI Biologics Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Croma-Pharma
2.12.1 Business Overview
2.12.2 Bone Morphogenetic Protein Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Croma-Pharma Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Zimmer Biomet
2.13.1 Business Overview
2.13.2 Bone Morphogenetic Protein Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Zimmer Biomet Bone Morphogenetic Protein Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bone Morphogenetic Protein Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Bone Morphogenetic Protein Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bone Morphogenetic Protein Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Bone Morphogenetic Protein Manufacturer Market Share in 2017
3.3.2 Top 6 Bone Morphogenetic Protein Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Bone Morphogenetic Protein Market Analysis by Regions
4.1 Global Bone Morphogenetic Protein Sales, Revenue and Market Share by Regions
4.1.1 Global Bone Morphogenetic Protein Sales and Market Share by Regions (2013-2018)
4.1.2 Global Bone Morphogenetic Protein Revenue and Market Share by Regions (2013-2018)
4.2 North America Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
4.3 Europe Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
4.5 South America Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
5 North America Bone Morphogenetic Protein by Countries
5.1 North America Bone Morphogenetic Protein Sales, Revenue and Market Share by Countries
5.1.1 North America Bone Morphogenetic Protein Sales and Market Share by Countries (2013-2018)
5.1.2 North America Bone Morphogenetic Protein Revenue and Market Share by Countries (2013-2018)
5.2 United States Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
5.3 Canada Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
5.4 Mexico Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
6 Europe Bone Morphogenetic Protein by Countries
6.1 Europe Bone Morphogenetic Protein Sales, Revenue and Market Share by Countries
6.1.1 Europe Bone Morphogenetic Protein Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Bone Morphogenetic Protein Revenue and Market Share by Countries (2013-2018)
6.2 Germany Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
6.3 UK Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
6.4 France Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
6.5 Russia Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
6.6 Italy Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
7 Asia-Pacific Bone Morphogenetic Protein by Countries
7.1 Asia-Pacific Bone Morphogenetic Protein Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bone Morphogenetic Protein Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Bone Morphogenetic Protein Revenue and Market Share by Countries (2013-2018)
7.2 China Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
7.3 Japan Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
7.4 Korea Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
7.5 India Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
8 South America Bone Morphogenetic Protein by Countries
8.1 South America Bone Morphogenetic Protein Sales, Revenue and Market Share by Countries
8.1.1 South America Bone Morphogenetic Protein Sales and Market Share by Countries (2013-2018)
8.1.2 South America Bone Morphogenetic Protein Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
8.3 Argentina Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
8.4 Colombia Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
9 Middle East and Africa Bone Morphogenetic Protein by Countries
9.1 Middle East and Africa Bone Morphogenetic Protein Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bone Morphogenetic Protein Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Bone Morphogenetic Protein Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
9.3 UAE Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
9.4 Egypt Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
9.5 Nigeria Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
9.6 South Africa Bone Morphogenetic Protein Sales and Growth Rate (2013-2018)
10 Global Bone Morphogenetic Protein Market Segment by Type
10.1 Global Bone Morphogenetic Protein Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bone Morphogenetic Protein Sales and Market Share by Type (2013-2018)
10.1.2 Global Bone Morphogenetic Protein Revenue and Market Share by Type (2013-2018)
10.2 rhBMP-2 Sales Growth and Price
10.2.1 Global rhBMP-2 Sales Growth (2013-2018)
10.2.2 Global rhBMP-2 Price (2013-2018)
10.3 rhBMP-7 Sales Growth and Price
10.3.1 Global rhBMP-7 Sales Growth (2013-2018)
10.3.2 Global rhBMP-7 Price (2013-2018)
11 Global Bone Morphogenetic Protein Market Segment by Application
11.1 Global Bone Morphogenetic Protein Sales Market Share by Application (2013-2018)
11.2 Spinal Fusion Sales Growth (2013-2018)
11.3 Trauma Sales Growth (2013-2018)
11.4 Reconstruction Sales Growth (2013-2018)
11.5 Oral Maxillofacial Sales Growth (2013-2018)
12 Bone Morphogenetic Protein Market Forecast (2018-2023)
12.1 Global Bone Morphogenetic Protein Sales, Revenue and Growth Rate (2018-2023)
12.2 Bone Morphogenetic Protein Market Forecast by Regions (2018-2023)
12.2.1 North America Bone Morphogenetic Protein Market Forecast (2018-2023)
12.2.2 Europe Bone Morphogenetic Protein Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bone Morphogenetic Protein Market Forecast (2018-2023)
12.2.4 South America Bone Morphogenetic Protein Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bone Morphogenetic Protein Market Forecast (2018-2023)
12.3 Bone Morphogenetic Protein Market Forecast by Type (2018-2023)
12.3.1 Global Bone Morphogenetic Protein Sales Forecast by Type (2018-2023)
12.3.2 Global Bone Morphogenetic Protein Market Share Forecast by Type (2018-2023)
12.4 Bone Morphogenetic Protein Market Forecast by Application (2018-2023)
12.4.1 Global Bone Morphogenetic Protein Sales Forecast by Application (2018-2023)
12.4.2 Global Bone Morphogenetic Protein Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bone Morphogenetic Protein Picture
Table Product Specifications of Bone Morphogenetic Protein
Figure Global Sales Market Share of Bone Morphogenetic Protein by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
